Skip to main content

Alpha Tau Medical Ltd.

DRTS
Exchange
Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
SEC CIK
0001871321

In the last 90 days, Alpha Tau Medical Ltd. insiders filed 0 open-market purchases and 4 sales; 74 institutions reported holding it in 13F filings for Q2 2026, worth $100.1M in total; ARK Invest is the only superinvestor holding it.

Other share classesDRTSW

Q3 2024 vs. Q2 2024

How the institutions holding Alpha Tau Medical Ltd. changed between Q2 2024 and Q3 2024.

All holders in Q3 2024All holders in Q2 2024

13F holders of DRTS: Q2 2024 compared with Q3 2024
MeasureQ2 2024Of which not filed for Q3 2024Q3 2024Change
Holders24223+1
Shares1.30M296.3K948.1K−52.5K (−5.2%)
Value$3.25M$749.6K$2.23M−$275.4K (−11.0%)

2 institutions that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so the changes leave them out.

New holders (4)

Institutions that held Alpha Tau Medical Ltd. at the end of Q3 2024 but not at the end of Q2 2024.

Institutions new to DRTS in Q3 2024
InstitutionSharesValue% of portfolio
Citadel Advisors LLC16,301$38.8K0.00%
Renaissance Technologies LLC14,200$33.8K0.00%
Cantor Fitzgerald, L. P.11,000$26.2K0.00%
UBS Group AG1,179$2.81K0.00%

Sold out (3)

Institutions that held Alpha Tau Medical Ltd. at the end of Q2 2024 and filed for Q3 2024 without it.

Institutions that sold out of DRTS in Q3 2024
InstitutionShares, Q2 2024Value, Q2 2024
Corbin Capital Partners, L.P.97,197$245.9K
CAPROCK Group, Inc.23,323$59.0K
Qube Research & Technologies Ltd24$61

Not filed for Q3 2024 yet (2)

Institutions that held Alpha Tau Medical Ltd. at the end of Q2 2024 and haven't filed a 13F for Q3 2024. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding DRTS in Q2 2024 that haven't filed for Q3 2024
InstitutionShares, Q2 2024Value, Q2 2024
Hoylecohen, LLC269,088$680.8K
Atalaya Capital Management LP27,180$68.8K